Delivery Order SPE2DB22D1200-SPE2DB24FN2PB

Award Date 5/16/24
Potential Completion Date 5/17/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, the prime contractor. The contract has a ceiling value of $3,153.90 and is a firm fixed-price delivery order. It has an ultimate completion date of August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the DLA, a defense agency, with the specified medication. This award is part of a...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,319.75, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,536.32 and a completion date of July 15, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract has an award value of $9,142.92 and a completion date of September 20, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $5,360.46, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 19, 2024, with an ultimate completion date of April 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a larger...
The federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an award value of $8,649.08 and a completion date of February 28, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,713.26 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,400.09. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 9, 2024. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $2,049.57 firm fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 9, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $9,590.46 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024 with a completion date of July 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN2PB
    Delivery Order

This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,975.72 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to the DLA in support of the Department of Defense's medical treatment programs and facilities worldwide. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation.

Generated 8/15/24, 9:18 AM